Gossamer Bio Inc (NASDAQ:GOSS)
| 11.49 BATS BZX Real-Time Price As of 11:48am ET |  +0.20 / +1.77%Today’s Change | 7.52 Today|||52-Week Range 27.15 | -26.49% Year-to-Date |
Latest GOSS News | Press Releases
| CRM, HPE, LRN and GOSS among after-hours movers Aug 25 / Seeking Alpha - Paid Partner Content |
Today’s Trading
| Previous close | 11.29 |
| Today’s open | 11.34 |
| Day’s range | 11.15 - 11.77 |
| Volume | 4,223 |
| Average volume (3 months) | 644,643 |
| Market cap | $994.9M |
Data as of 11:48am ET, 09/24/2020
Growth & Valuation
| Earnings growth (last year) | -47.64% |
| Earnings growth (this year) | -10.38% |
| Earnings growth (next 5 years) | +5.19% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 2.29 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PETQPetIQ Inc | +0.99 | +3.31% |
| AMPHAmphastar Pharmaceut... | -0.19 | -1.04% |
| ENTAEnanta Pharmaceutica... | -0.38 | -0.88% |
| CNSTConstellation Pharma... | +0.20 | +1.14% |
Data as of 11:56am ET, 09/24/2020
Financials
| Next reporting date | November 17, 2020 |
| EPS forecast (this quarter) | -$0.86 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$180.3M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
